Your browser doesn't support javascript.
loading
A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19.
Wagener, Gebhard; Goldklang, Monica P; Gerber, Adam; Elisman, Katerina; Eiseman, Katherine A; Fonseca, Laura D; D'Armiento, Jeanine M.
Afiliación
  • Wagener G; Department of Anesthesiology, Columbia University Irving Medical Center, 622 West 168th Street, PH 5, New York, NY, 10032, USA.
  • Goldklang MP; Department of Anesthesiology, Columbia University Irving Medical Center, 622 West 168th Street, PH 5, New York, NY, 10032, USA.
  • Gerber A; Department of Anesthesiology, Columbia University Irving Medical Center, 622 West 168th Street, PH 5, New York, NY, 10032, USA.
  • Elisman K; Department of Anesthesiology, Columbia University Irving Medical Center, 622 West 168th Street, PH 5, New York, NY, 10032, USA.
  • Eiseman KA; Department of Anesthesiology, Columbia University Irving Medical Center, 622 West 168th Street, PH 5, New York, NY, 10032, USA.
  • Fonseca LD; Columbia University Vagelos College of Physicians and Surgeons, New York-Prebysterian Columbia University Medical Center, 630 West 168th Street, New York, NY, 10032, USA.
  • D'Armiento JM; Department of Anesthesiology, Columbia University Irving Medical Center, 622 West 168th Street, PH 5, New York, NY, 10032, USA.
Crit Care ; 26(1): 229, 2022 07 28.
Article en En | MEDLINE | ID: mdl-35902867

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ácido Tranexámico / COVID-19 / Antifibrinolíticos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Crit Care Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ácido Tranexámico / COVID-19 / Antifibrinolíticos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Crit Care Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos